Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting

Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting

Saved in:
Bibliographic Details
Main Authors: Emma L. Myers, BA, Jessica Liu, BA, Sabrina M. Shearer, MD, Sarah A. Myers, MD, Michelle Schneider, MB, BCh, BAO, Christopher Hoimes, DO, Melodi Javid Whitley, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:JAAD Case Reports
Subjects:
enfortumab
immune checkpoint inhibitor
immunotherapy
oncodermatology
pembrolizumab
severe cutaneous adverse reaction
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512625000190
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items